All Topics

Subscribe
Article
Belgian Pharma Law Summer Blog Series (Part 3): The Recently Passed ‘Bill Containing Various Provisions On Health’
Belgium's federal Chamber of Representatives has adopted a comprehensive bill introducing significant changes to pharmaceutical reimbursement procedures, including simplified approval tracks, new combination therapy rules, and an 80 million EUR annual industry contribution. The legislation also addresses drug unavailability issues and postpones certain 2024 reforms until 2028, fundamentally reshaping the financial and operational landscape for pharmaceutical companies operating in Belgium.
Belgium Healthcare
A
Altius
Article
Limited Payment Terms In B2B Relationships
New Belgian legislation introduces stricter payment terms for business-to-business transactions, capping payment periods at 60 days and eliminating contractual flexibility around invoice receipt dates. The Act of 14 August 2021 strengthens protections for creditors by imposing automatic penalties on late-paying debtors, including a 10.5% interest rate and fixed recovery costs, fundamentally reshaping commercial payment practices.
Belgium Commercial
A
Altius
See more